These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 782731)

  • 21. [Gram-positive bacteria as adjuvants (author's transl)].
    Hahn H
    Immun Infekt; 1978 Jun; 6(3):123-6. PubMed ID: 96006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative antitumoral cytostatic effect of splenic or peritoneal cells of mice with teratocarcinoma or immunized with tumoral cells. Stimulating effect of BCG and cyclophosphamide].
    Christen Y
    C R Acad Hebd Seances Acad Sci D; 1974 Nov; 279(22):1729-32. PubMed ID: 4219181
    [No Abstract]   [Full Text] [Related]  

  • 24. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
    Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
    Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated macrophages and the antitumor action of BCG.
    Alexander P
    Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunologic and cytokinetic parameters of BCG-induced growth control of a murine leukemia.
    Olsson L
    Recent Results Cancer Res; 1977; (62):28-35. PubMed ID: 601336
    [No Abstract]   [Full Text] [Related]  

  • 28. Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains.
    Boraschi D; Meltzer MS
    Cell Immunol; 1979 Jun; 45(1):188-94. PubMed ID: 378423
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages.
    Bonventre PF; Straus D; Baughn RE; Imhoff J
    J Immunol; 1977 May; 118(5):1827-35. PubMed ID: 404359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in normal mice.
    Wolmark N; Levine M; Fisher B
    J Reticuloendothel Soc; 1974 Oct; 16(4):252-7. PubMed ID: 4455907
    [No Abstract]   [Full Text] [Related]  

  • 31. Induction of macrophage-mediated tumor-cell cytotoxicity by pyran copolymer.
    Kaplan AM; Morahan PS; Regelson W
    J Natl Cancer Inst; 1974 Jun; 52(6):1919-23. PubMed ID: 4834420
    [No Abstract]   [Full Text] [Related]  

  • 32. Separation of functionally distinct subpopulations of Corynebacterium parvum-activated macrophages with predominantly stimulatory or suppressive effect on the cell-mediated cytotoxic T cell response.
    Lee KC; Kay J; Wong M
    Cell Immunol; 1979 Jan; 42(1):28-41. PubMed ID: 312146
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationship between intradermal tumor suppression and tumor immunity.
    Bartlett GL; Kreider JW; Purnell DM
    J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mode of action of mycobacterial fractions in antitumor immunity: preliminary evidence for a direct nonspecific stimulatory effect of MER on immunologically reactive cells.
    Weiss DW; Kuperman O; Fathallah N; Kedar E
    Ann N Y Acad Sci; 1976; 276():536-49. PubMed ID: 1071978
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of treatment of C57BL-6 mice with the methanol extraction residue fraction of BCG on leukemogenesis induced by the radiation leukemia virus.
    Haran-Ghera N; Weiss DW
    J Natl Cancer Inst; 1973 Jan; 50(1):229-34. PubMed ID: 4348221
    [No Abstract]   [Full Text] [Related]  

  • 36. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
    Germain RN; Williams RM; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [BCG and experimental leukemia].
    Amiel JL; Berardet M
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):701-14. PubMed ID: 4559236
    [No Abstract]   [Full Text] [Related]  

  • 38. Bidirectional amplification of macrophage-lymphocyte interactions: enhanced lymphocyte activation factor production by activated adherent mouse peritoneal cells.
    Meltzer MS; Oppenheim JJ
    J Immunol; 1977 Jan; 118(1):77-82. PubMed ID: 137265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of immunostimulating agents on viral infections.
    Zerial A; Werner GH
    Acta Microbiol Acad Sci Hung; 1981; 28(3):325-37. PubMed ID: 6171144
    [No Abstract]   [Full Text] [Related]  

  • 40. The mechanism of immunoresistance of H(z1) mice to C57BL/6 tumors.
    Chauvenet PH; Amos DB
    Cell Immunol; 1975 Jun; 17(2):477-86. PubMed ID: 1125995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.